Global Sustained Release Ocular Drug Delivery Systems Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Sustained Release Ocular Drug Delivery Systems market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Sustained Release Ocular Drug Delivery Systems is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Sustained Release Ocular Drug Delivery Systems include Aciont Inc., Allergan, Envisia Therapeutics, GrayBug, Icon Bioscience, Innocore Pharmaceuticals, Neurotech Pharmaceuticals, Ocular Therapeutix and OHR Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sustained Release Ocular Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Ocular Drug Delivery Systems.

The Sustained Release Ocular Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sustained Release Ocular Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Sustained Release Ocular Drug Delivery Systems Segment by Company

Aciont Inc.
Allergan
Envisia Therapeutics
GrayBug
Icon Bioscience
Innocore Pharmaceuticals
Neurotech Pharmaceuticals
Ocular Therapeutix
OHR Pharmaceuticals
PolyActiva
pSivida
TheraKine
Santen Pharmaceutical

Sustained Release Ocular Drug Delivery Systems Segment by Type

Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Liposome
Implants

Sustained Release Ocular Drug Delivery Systems Segment by Application

Glaucoma
Corneal Transplantation
Cataract
Others

Sustained Release Ocular Drug Delivery Systems Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sustained Release Ocular Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sustained Release Ocular Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sustained Release Ocular Drug Delivery Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sustained Release Ocular Drug Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sustained Release Ocular Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales Estimates and Forecasts (2020-2031)
1.3 Sustained Release Ocular Drug Delivery Systems Market by Type
1.3.1 Microcapsules/Nanocapsules
1.3.2 Microspheres/Nanosptheres
1.3.3 Liposome
1.3.4 Implants
1.4 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Overview by Type (2020-2031)
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size Review by Type (2020-2025)
1.4.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2020-2025)
1.5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2020-2025)
1.5.4 South America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
2.2 Sustained Release Ocular Drug Delivery Systems Industry Drivers
2.3 Sustained Release Ocular Drug Delivery Systems Industry Opportunities and Challenges
2.4 Sustained Release Ocular Drug Delivery Systems Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Sustained Release Ocular Drug Delivery Systems Revenue (2020-2025)
3.2 Global Top Players by Sustained Release Ocular Drug Delivery Systems Sales (2020-2025)
3.3 Global Top Players by Sustained Release Ocular Drug Delivery Systems Price (2020-2025)
3.4 Global Sustained Release Ocular Drug Delivery Systems Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Sustained Release Ocular Drug Delivery Systems Major Company Production Sites & Headquarters
3.6 Global Sustained Release Ocular Drug Delivery Systems Company, Product Type & Application
3.7 Global Sustained Release Ocular Drug Delivery Systems Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Sustained Release Ocular Drug Delivery Systems Market CR5 and HHI
3.8.2 Global Top 5 and 10 Sustained Release Ocular Drug Delivery Systems Players Market Share by Revenue in 2024
3.8.3 2023 Sustained Release Ocular Drug Delivery Systems Tier 1, Tier 2, and Tier 3
4 Sustained Release Ocular Drug Delivery Systems Regional Status and Outlook
4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size by Region
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2020-2025)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2020-2025)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Region
4.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2026-2031)
4.3.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2026-2031)
4.3.3 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Sustained Release Ocular Drug Delivery Systems by Application
5.1 Sustained Release Ocular Drug Delivery Systems Market by Application
5.1.1 Glaucoma
5.1.2 Corneal Transplantation
5.1.3 Cataract
5.1.4 Others
5.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Overview by Application (2020-2031)
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size Review by Application (2020-2025)
5.2.3 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2020-2025)
5.3.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2020-2025)
5.3.4 South America Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Aciont Inc.
6.1.1 Aciont Inc. Comapny Information
6.1.2 Aciont Inc. Business Overview
6.1.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.1.5 Aciont Inc. Recent Developments
6.2 Allergan
6.2.1 Allergan Comapny Information
6.2.2 Allergan Business Overview
6.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.2.5 Allergan Recent Developments
6.3 Envisia Therapeutics
6.3.1 Envisia Therapeutics Comapny Information
6.3.2 Envisia Therapeutics Business Overview
6.3.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.3.5 Envisia Therapeutics Recent Developments
6.4 GrayBug
6.4.1 GrayBug Comapny Information
6.4.2 GrayBug Business Overview
6.4.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GrayBug Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.4.5 GrayBug Recent Developments
6.5 Icon Bioscience
6.5.1 Icon Bioscience Comapny Information
6.5.2 Icon Bioscience Business Overview
6.5.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.5.5 Icon Bioscience Recent Developments
6.6 Innocore Pharmaceuticals
6.6.1 Innocore Pharmaceuticals Comapny Information
6.6.2 Innocore Pharmaceuticals Business Overview
6.6.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.6.5 Innocore Pharmaceuticals Recent Developments
6.7 Neurotech Pharmaceuticals
6.7.1 Neurotech Pharmaceuticals Comapny Information
6.7.2 Neurotech Pharmaceuticals Business Overview
6.7.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.7.5 Neurotech Pharmaceuticals Recent Developments
6.8 Ocular Therapeutix
6.8.1 Ocular Therapeutix Comapny Information
6.8.2 Ocular Therapeutix Business Overview
6.8.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.8.5 Ocular Therapeutix Recent Developments
6.9 OHR Pharmaceuticals
6.9.1 OHR Pharmaceuticals Comapny Information
6.9.2 OHR Pharmaceuticals Business Overview
6.9.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.9.5 OHR Pharmaceuticals Recent Developments
6.10 PolyActiva
6.10.1 PolyActiva Comapny Information
6.10.2 PolyActiva Business Overview
6.10.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.10.5 PolyActiva Recent Developments
6.11 pSivida
6.11.1 pSivida Comapny Information
6.11.2 pSivida Business Overview
6.11.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 pSivida Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.11.5 pSivida Recent Developments
6.12 TheraKine
6.12.1 TheraKine Comapny Information
6.12.2 TheraKine Business Overview
6.12.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.12.4 TheraKine Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.12.5 TheraKine Recent Developments
6.13 Santen Pharmaceutical
6.13.1 Santen Pharmaceutical Comapny Information
6.13.2 Santen Pharmaceutical Business Overview
6.13.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Portfolio
6.13.5 Santen Pharmaceutical Recent Developments
7 North America by Country
7.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Country
7.1.1 North America Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025)
7.1.3 North America Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2026-2031)
7.2 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country
7.2.1 North America Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country (2020-2025)
7.2.3 North America Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country
8.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025)
8.1.3 Europe Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2026-2031)
8.2 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country
8.2.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country (2020-2025)
8.2.3 Europe Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Country
9.1.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025)
9.1.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Country
9.2.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Sustained Release Ocular Drug Delivery Systems Sales by Country
10.1.1 South America Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025)
10.1.3 South America Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2026-2031)
10.2 South America Sustained Release Ocular Drug Delivery Systems Market Size by Country
10.2.1 South America Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Sustained Release Ocular Drug Delivery Systems Market Size by Country (2020-2025)
10.2.3 South America Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country
11.1.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2020-2025)
11.1.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Country
11.2.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Sustained Release Ocular Drug Delivery Systems Value Chain Analysis
12.1.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Sustained Release Ocular Drug Delivery Systems Production Mode & Process
12.2 Sustained Release Ocular Drug Delivery Systems Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Sustained Release Ocular Drug Delivery Systems Distributors
12.2.3 Sustained Release Ocular Drug Delivery Systems Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings